- Report
- August 2024
- 159 Pages
Global
From €2854EUR$2,990USD£2,391GBP
- Report
- October 2024
- 185 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- March 2025
- 210 Pages
Global
From €5535EUR$5,800USD£4,638GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- June 2024
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- September 2024
- 140 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- December 2024
- 150 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- November 2024
- 350 Pages
Global
From €3813EUR$3,995USD£3,195GBP
- Report
- March 2025
- 546 Pages
Global
From €6676EUR$6,995USD£5,593GBP
- Report
- November 2024
- 563 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- July 2024
- 153 Pages
Global
From €4252EUR$4,455USD£3,562GBP
€4724EUR$4,950USD£3,958GBP
- Report
- October 2024
- 112 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- August 2024
- 137 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- March 2025
- 184 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 191 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- October 2024
- 186 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- February 2025
- 180 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- February 2025
- 172 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 93 Pages
Global
From €5345EUR$5,600USD£4,478GBP
- Report
- March 2025
- 89 Pages
Global
From €5345EUR$5,600USD£4,478GBP

The Genomics Artificial Intelligence (AI) market is a rapidly growing sector of the genomics industry. It is focused on the development of AI-based solutions to enable the analysis of large-scale genomic data. These solutions are used to identify genetic variants associated with diseases, to develop personalized treatments, and to improve the accuracy of diagnostics. AI-based solutions are also used to identify novel drug targets and to develop new drugs.
The Genomics AI market is driven by the increasing availability of genomic data, the need for more accurate and personalized treatments, and the growing demand for AI-based solutions. The market is expected to continue to grow in the coming years, as more genomic data is collected and AI-based solutions become more widely adopted.
Some companies in the Genomics AI market include Illumina, BGI, Thermo Fisher Scientific, Genomics plc, and DNAnexus. Show Less Read more